Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The record presents details of the Cabozantinib study for advanced adrenocortical carcinoma, including eligibility criteria, treatment plan, outcomes, study dates, and German locations. It also indicates an unknown current status, with the last known status listed as active, not recruiting.
    Difference
    49%
    Check dated 2026-11-08T00:47:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0, while the 403 error page remained otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-31T19:10:38.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice about NIH website terminology changes appears above the ClinicalTrials.gov page. The underlying study record still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:11:54.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T20:16:32.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:39:03.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with the header and footer present but the study content not shown. This indicates an access/server issue rather than a substantive update to the page content.
    Difference
    18%
    Check dated 2026-09-19T20:31:04.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.